40
Immorta Bio, Inc. raises $450K under Reg D
Company raise · Raising · Offering $500K · Sold $450K · MIAMI BEACH, FL · filed 2026-01-08
40
Immorta Bio raises $5M under Reg D 506(c) in Miami Beach biotech round
Company raise · Raising · MIAMI BEACH, FL · Form D filed 2026-10-16
Immorta Bio, a Delaware biotech corporation incorporated in 2023, is raising $5M under Regulation D 506(c) with general solicitation. The company has sold $613K to 6 investors so far with a $45K minimum and $4.39M remaining in the offering.
other
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Boris Reznik | Executive Officer |
Signed by Brian Chaiken, General Counsel.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.